OpenURL Connection Search

Select item for more details and to access through your institution.

Outcome of patients with low-grade B cell non-Hodgkin lymphoma and initial bone marrow involvement: data of a single institution.
Published in:
Leukemia (08876924), 1997, v. 11, p. S52
By:
- Heinz, R.;
- Hopfinger, G.;
- Tüchler, H.
Publication type:
Article
Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.
Published in:
Annals of Hematology, 2014, v. 93, n. 2, p. 267, doi. 10.1007/s00277-013-1966-z
By:
- Fiegl, M.;
- Stauder, R.;
- Steurer, M.;
- Mian, M.;
- Hopfinger, G.;
- Brychtova, Y.;
- Skrabs, C.;
- Zabernigg, A.;
- Schmid, F.;
- Haslbaur, F.;
- Winder, G.;
- Walder, A.;
- Lang, A.;
- Voskova, D.;
- Greil, R.;
- Mayer, J.;
- Gastl, G.
Publication type:
Article
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.
Published in:
European Journal of Haematology, 1995, v. 55, n. 4, p. 223, doi. 10.1111/j.1600-0609.1995.tb00261.x
By:
- Hopfinger, G.;
- Heinz, R.;
- Koller, E.;
- Schneider, B.;
- Pittermann, E.
Publication type:
Article
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
Published in:
Leukemia (08876924), 2013, v. 27, n. 9, p. 1949, doi. 10.1038/leu.2013.190
By:
- Fink, A M;
- Böttcher, S;
- Ritgen, M;
- Fischer, K;
- Pflug, N;
- Eichhorst, B;
- Wendtner, C-M;
- Winkler, D;
- Bühler, A;
- Zenz, T;
- Staib, P;
- Mayer, J;
- Hensel, M;
- Hopfinger, G;
- Wenger, M;
- Fingerle-Rowson, G;
- Döhner, H;
- Kneba, M;
- Stilgenbauer, S;
- Busch, R
Publication type:
Article
Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.
Published in:
2010
By:
- Shehata, M.;
- Demirtas, D.;
- Schnabl, S.;
- Hilgarth, M.;
- Hubmann, R.;
- Fonatsch, C.;
- Schwarzinger, I.;
- Hopfinger, G.;
- Eigenberger, K.;
- Heintel, D.;
- Porpaczy, E.;
- Vanura, K.;
- Hauswirth, A.;
- Schwarzmeier, J. D.;
- Gaiger, A.;
- Stilgenbauer, S.;
- Hallek, M.;
- Bilban, M.;
- Jäger, U.
Publication type:
Letter
Chronische lymphatische Leukämie Aktuelle Therapiekonzepte.
Published in:
Der Internist, 2002, v. 43, n. 10, p. 1245, doi. 10.1007/s00108-002-0707-5
By:
- Hallek, M.;
- Bergmann, M.;
- Brittinger, G.;
- Döhner, H.;
- Dreger, P.;
- Herold, M.;
- Hopfinger, G.;
- Jäger, U.;
- Knauf, W.;
- Nerl, C.;
- Rummel, M.;
- Schmitt, B.;
- Wendtner, C.M.;
- Emmerich, B.
Publication type:
Article

Found: 6

Outcome of patients with low-grade B cell non-Hodgkin lymphoma and initial bone marrow involvement: data of a single institution.

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.

Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.

Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.

Chronische lymphatische Leukämie Aktuelle Therapiekonzepte.